JNJ

185.89

-1.63%↓

ABT

123.99

+0.91%↑

TMO

560.72

+0.41%↑

ISRG

537.8

+0.95%↑

DHR

212.49

-0.41%↓

JNJ

185.89

-1.63%↓

ABT

123.99

+0.91%↑

TMO

560.72

+0.41%↑

ISRG

537.8

+0.95%↑

DHR

212.49

-0.41%↓

JNJ

185.89

-1.63%↓

ABT

123.99

+0.91%↑

TMO

560.72

+0.41%↑

ISRG

537.8

+0.95%↑

DHR

212.49

-0.41%↓

JNJ

185.89

-1.63%↓

ABT

123.99

+0.91%↑

TMO

560.72

+0.41%↑

ISRG

537.8

+0.95%↑

DHR

212.49

-0.41%↓

JNJ

185.89

-1.63%↓

ABT

123.99

+0.91%↑

TMO

560.72

+0.41%↑

ISRG

537.8

+0.95%↑

DHR

212.49

-0.41%↓

Search

iRhythm Technologies Inc

Затворен

СекторЗдравеопазване

184.31 -0.86

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

181.05

Максимум

188.7

Ключови измерители

By Trading Economics

Приходи

16M

-14M

Продажби

28M

187M

Марж на печалбата

-7.616

Служители

2,000

EBITDA

27M

-5.4M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+17.26% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

1.5B

5.9B

Предишно отваряне

185.17

Предишно затваряне

184.31

Настроения в новините

By Acuity

33%

67%

88 / 373 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

iRhythm Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.11.2025 г., 21:44 ч. UTC

Печалби

Vertex Pharmaceuticals Revenue Climbs on Demand for Cystic Fibrosis Drugs

3.11.2025 г., 23:44 ч. UTC

Пазарно говорене

Nikkei May Rise on Weaker Yen, Hopes for Govt Econ Steps -- Market Talk

3.11.2025 г., 23:34 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Lingering Worry Over China's Ending of Tax Incentive -- Market Talk

3.11.2025 г., 23:28 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- 2nd Update

3.11.2025 г., 23:24 ч. UTC

Печалби

Correct: Grab Holdings Sees FY2025 Adj Ebitda $490M-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3.11.2025 г., 23:14 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

3.11.2025 г., 23:14 ч. UTC

Пазарно говорене
Придобивния, сливания и поглъщания

Deterra's Next CEO Might Bring New Approach to Deals -- Market Talk

3.11.2025 г., 23:12 ч. UTC

Печалби

Grab Holdings Sees FY2025 Adj Ebitda $490-$500.0M, Higher Than $460M-$480M Projected in 2Q >GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q 2Q Adj EBITDA $136.0M Vs. $90.0M>GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q Net $17.0M Vs. Net $15.0M >GRAB

3.11.2025 г., 23:09 ч. UTC

Печалби

Grab Holdings 3Q Rev $873.0M Vs. $716.0M >GRAB

3.11.2025 г., 23:06 ч. UTC

Пазарно говорене
Печалби

Palantir Execs Forecast Future of U.S. Workers In AI World -- Market Talk

3.11.2025 г., 22:36 ч. UTC

Пазарно говорене
Печалби

Palantir's U.S. Commercial Business Booms as It Expands AI -- Market Talk

3.11.2025 г., 22:31 ч. UTC

Печалби

Franco-Nevada 3Q EPS $1.49 >FNV

3.11.2025 г., 22:31 ч. UTC

Печалби

Franco-Nevada 3Q Rev $487.7M >FNV

3.11.2025 г., 22:24 ч. UTC

Пазарно говорене

Xero Bulls Expect Improving U.S. Momentum in 1H -- Market Talk

3.11.2025 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Starbucks Agrees to Sell Stake in China Business -- WSJ

3.11.2025 г., 21:59 ч. UTC

Пазарно говорене

RBA Set To Keep Rates On Hold; Remain Data Dependent -- Market Talk

3.11.2025 г., 21:54 ч. UTC

Пазарно говорене
Печалби

Westpac's Tech Challenge Keeps Jefferies Cautious -- Market Talk

3.11.2025 г., 21:54 ч. UTC

Пазарно говорене
Печалби

Global Equities Roundup: Market Talk

3.11.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

3.11.2025 г., 21:49 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- Update

3.11.2025 г., 21:40 ч. UTC

Печалби

Barry Diller's IAC Inks AI Deal With Microsoft. That Isn't Why the Stock Is Sliding. -- Barrons.com

3.11.2025 г., 21:31 ч. UTC

Пазарно говорене

Mexican Manufacturing Indexes Pick Up in October -- Market Talk

3.11.2025 г., 21:19 ч. UTC

Печалби

Palantir Revenue Hits Another Record as Defense Work Booms -- WSJ

3.11.2025 г., 21:11 ч. UTC

Придобивния, сливания и поглъщания

Pfizer Reports Earnings Tuesday. Management Has Big Questions to Answer. -- Barrons.com

3.11.2025 г., 21:11 ч. UTC

Печалби

Diamondback Energy: Increasing Full Yr Oil Production Guidance to 495-498 MBO/d and Increasing Annual BOE Guidance to 910-920 MBOE/d >FANG

3.11.2025 г., 21:07 ч. UTC

Печалби

Palantir Technologies: Raising 2025 U.S. Comml Rev Guidance to in Excess of $1.433B, Representing a Growth Rate of at Least 104% >PLTR

3.11.2025 г., 21:05 ч. UTC

Печалби

Vertex Pharmaceutic Sees 2025 Rev $11.9B-$12B >VRTX

3.11.2025 г., 21:05 ч. UTC

Печалби

Palantir Technologies 3Q Net $475.6M >PLTR

Сравнение с други в отрасъла

Ценова промяна

iRhythm Technologies Inc Прогноза

Ценова цел

By TipRanks

17.26% нагоре

12-месечна прогноза

Среден 219.62 USD  17.26%

Висок 244 USD

Нисък 185 USD

Според 14 анализатори от Wall Street, предложили 12-месечна ценова цел за iRhythm Technologies Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

14 ratings

12

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

104.78 / 137.91Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Strong Bullish Evidence

Дългосрочен план

Bullish Evidence

Настроение

By Acuity

88 / 373 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
help-icon Live chat